APN News

  • Saturday, December, 2023| Today's Market | Current Time: 07:02:55
  • New and enhanced features of Planmed Verity® receive FDA approval

    Published on December 7, 2018

    The U.S. Food and Drug Administration (FDA) has issued an approval letter for the new features and intended uses of the Planmed Verity® CBCT scanner. Planmed is very pleased to bring these exciting improvements to the U.S. market.

    The U.S. Food and Drug Administration (FDA) issued an approval letter for the new features and intended uses of the Planmed Verity® orthopedic imaging solution on November 30th, 2018.

    The improved Planmed Verity now offers enhanced image quality as well as new options for head and neck imaging, the Planmeca Ultra Low Dose™ imaging protocol for lower patient doses, and Planmeca CALM™ algorithm for motion artifact correction.

    “We are excited to release the improved, XR-29 compliant Planmed Verity with its new dental and ENT imaging options. These features are something our customers have requested, and we are happy to answer their needs,” says Johan Moed, National Sales Manager of Planmed USA. “This unit is now more versatile than ever before. It is an easy-to-use and cost-effective solution, which makes it a great tool for any imaging center, clinic or hospital.”

    The new enhancements include the iterative Planmeca CALM algorithm, which reduces artifacts caused by patient movement. The groundbreaking Planmeca CALM is especially useful in challenging weight-bearing examinations in which patients have a tendency to move. Meanwhile, the innovative Planmeca Ultra Low Dose™ (ULD) imaging protocol enables reducing Planmed Verity’s already low effective patient doses even further – without compromising diagnostic image quality.

    “The work done on the iterative algorithms further strengthens our commitment to offering high quality imaging solutions with extremely low patient radiation doses. We are delighted to start delivering scanners with these exciting features to our customers in the United States,” Moed concludes.


    Leave a Reply